Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Steadymed Ltd Ord Sh (STDY)

Steadymed Ltd Ord Sh (STDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Steadymed Ltd Ord Sh 5 OPPENHEIMER STREET REHOVOT L3 7670105 ISR

www.steadymed.com P: 925-272-4999

Description:

SteadyMed Ltd. is a specialty pharmaceutical company which focused on the development of drug products to treat orphan and other diseases. The company's lead candidate consist of Trevyent(R), a development stage drug product which utilizes SteadyMed's PatchPump(R) technology to treat pulmonary arterial hypertension. SteadyMed Ltd. is headquartered in San Ramon, California.

Key Statistics

Overview:

Market Capitalization, $K 126,347
Shares Outstanding, K 26,740
Annual Sales, $ 1,070 K
Annual Net Income, $ -23,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,360 K
60-Month Beta 0.47
% of Insider Shareholders 38.63%
% of Institutional Shareholders 43.76%

Growth:

1-Year Return -23.81%
3-Year Return 23.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/17/18
Earnings Per Share ttm -0.96
EPS Growth vs. Prev Qtr 2.56%
EPS Growth vs. Prev Year -15.15%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STDY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -94.69%
Return-on-Assets % -47.15%
Profit Margin % -2,169.16%
Debt/Equity 0.00
Price/Sales 119.28
Price/Cash Flow N/A
Price/Book 29.19
Book Value/Share -0.52
Interest Coverage -7.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar